Abstract:We have previously shown that mitochondria-targeted vitamin E (Mito-Vit-E), a mtROS specific antioxidant, improves cardiac performance and attenuates inflammation in a pneumonia-related sepsis model. In this study, we applied the same approaches to decipher the signaling pathway(s) of mtROS-dependent cardiac inflammation after sepsis. Sepsis was induced in Sprague Dawley rats by intratracheal injection of S. pneumoniae. Mito-Vit-E, vitamin E or vehicle was administered 30 minutes later. In myocardium 24 hours post-inoculation, Mito-Vit-E, but not vitamin E, significantly protected mtDNA integrity and decreased mtDNA damage. Mito-Vit-E alleviated sepsis-induced reduction in mitochondria-localized DNA repair enzymes including DNA polymerase γ, AP endonuclease, 8-oxoguanine glycosylase, and uracil-DNA glycosylase. Mito-Vit-E dramatically improved metabolism and membrane integrity in mitochondria, suppressed leakage of mtDNA into the cytoplasm, inhibited up-regulation of Toll-like receptor 9 (TLR9) pathway factors MYD88 and RAGE, and limited RAGE interaction with its ligand TFAM in septic hearts. Mito-Vit-E also deactivated NF-κB and caspase 1, reduced expression of the essential inflammasome component ASC, and decreased inflammatory cytokine IL-1β. In vitro, both Mito-Vit-E and TLR9 inhibitor OND-I suppressed LPS-induced up-regulation in MYD88, RAGE, ASC, active caspase 1, and IL-1β in cardiomyocytes. Since free mtDNA escaped from damaged mitochondria function as a type of DAMPs to stimulate inflammation through TLR9, these data together suggest that sepsis-induced cardiac inflammation is mediated, at least partially, through mtDNA-TLR9-RAGE. At last, Mito-Vit-E reduced the circulation of myocardial injury marker troponin-I, diminished apoptosis and amended morphology in septic hearts, suggesting that mitochondria-targeted antioxidants are a potential cardioprotective approach for sepsis.

Sepsis induced myocardial mitochondrial oxidative damage in the elderly

Mitochondrial Injury and Targeted Intervention in Septic Cardiomyopathy.

Mitochondrial quality control mechanisms as potential therapeutic targets in sepsis-induced multiple organ failure

Therapeutic Strategies Targeting Mitochondrial Dysfunction in Sepsis-induced Cardiomyopathy

Mechanism of Mitophagy and Its Role in Sepsis Induced Organ Dysfunction: A Review

Mitochondrial Dysfunction: A Roadmap for Understanding and Tackling Cardiovascular Aging.

Progress in the Mechanism of Mitochondrial Dysfunction in Septic Cardiomyopathy

Mitochondrial dysfunction in sepsis: mechanisms and therapeutic perspectives

Mitochondrial ROS Induces Cardiac Inflammation via a Pathway through mtDNA Damage in a Pneumonia-Related Sepsis Model

Progress of Antioxidant Therapy in Sepsis

Current Perspectives of Mitochondria in Sepsis-Induced Cardiomyopathy

[Research progress of mitochondrial dysfunction in the pathogenesis of septic acute kidney injury].

Mitochondria and Reactive Oxygen Species in Aging and Age-Related Diseases

Potential Therapy Strategy: Targeting Mitochondrial Dysfunction in Sepsis

An Overview on Mitochondrial-Based Therapies in Sepsis-Related Myocardial Dysfunction: Mitochondrial Transplantation as a Promising Approach

Sepsis-Induced Myocardial Dysfunction (SIMD): the Pathophysiological Mechanisms and Therapeutic Strategies Targeting Mitochondria

Mitochondria and oxidative stress in heart aging

Advances in Cardiotoxicity Induced by Altered Mitochondrial Dynamics and Mitophagy

Age-Dependent Myocardial Dysfunction in Critically Ill Patients: Role of Mitochondrial Dysfunction

Mitochondrial Damage in Sepsis

Sepsis in elderly patients: the role of neutrophils in pathophysiology and therapy